Brief: Penumbra Inc - Stockholders Approve Merger With Boston Scientific - SEC Filing
May 7 (Reuters) - Penumbra Inc PEN.N: PENUMBRA INC - STOCKHOLDERS APPROVE MERGER WITH BOSTON SCIENTIFIC - SEC FILING Source text: [] Further company coverage: PEN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Penumbra
See all newsPenumbra Inc reports results for the quarter ended June 30 - Earnings Summary
Penumbra Q2 revenue slightly beats estimates, helped by product segment increase
Brief: Penumbra Q2 Revenue USD 390.046 Million Vs. IBES Estimate USD 389 Million
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade